Ad
related to: united states coronavirus update
Search results
Biden hiking tariffs on Chinese EVs, solar cells, steel, aluminum — adding to tensions with Beijing
The Columbian· 2 days agoThe Biden administration announced plans to slap new tariffs on Chinese electric vehicles, advanced...
10,000 websites, 10 years: Inside the U.S. government's behemoth plan to overhaul its online...
Fast Company Magazine· 3 days agoU.S. government websites are notoriously difficult to use. The government is undertaking a massive overhaul to update and standardize more than 10,000 web pages used by more ...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
Morningstar· 6 days agoSHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan ...
TFI International Inc. (NYSE:TFII) Receives Consensus Recommendation of “Moderate Buy” from...
ETF DAILY NEWS· 3 days agoTFI International Inc. (NYSE:TFII – Get Free Report) has been assigned an average rating of...
A Novel Broad-Spectrum Antiviral with Activity Against RSV
Digital Journal· 2 days agoSHELTON, CT / ACCESSWIRE / May 14, 2024 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity of NV ...
AP News Summary at 5:13 p.m. EDT
The Longview News-Journal· 7 days agoPrime Minister Benjamin Netanyahu said Thursday that a U.S. threat to withhold some arms would not prevent Israel from continuing its offensive in Gaza, indicating it might proceed with an invasion ...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
Digital Journal· 6 days agoSHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $50.80 Average Target Price from Brokerages
ETF DAILY NEWS· 5 days agoFree Report) has been given an average recommendation of “Moderate Buy” by the eleven brokerages that are presently covering the stock, MarketBeat.com reports. The average 1 year target price ...
Judge dismisses lawsuit over Iowa ending COVID benefits early
Sioux City Journal· 5 days agoA U.S. District Court judge on Friday dismissed a class-action lawsuit over Iowa Gov. Kim Reynolds’...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoPositive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart